Antimicrobial activity of 1,4-naphthoquinones by metal complexation

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 40, Issue 2, 2004, Pages 247-253

  Brandelli, Adriano ^a   Bizani, Delmar ^a   Martinelli, Márcia ^a   Stefani, Valter ^a   Gerbase, Annelise Engel ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

5 Amino 8 hydroxy 1,4 naphtoquinone; Antimicrobial; Hydroxyquinone; Metal chelate; Staphylococci

Indexed keywords

1,4 NAPHTHOQUINONE; 5 ACETYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 AMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 DECANOYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 DODECANOYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 HEXADECANOYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 OCTANOYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; 5 TETRADECANOYLAMINO 8 HYDROXY 1,4 NAPHTHOQUINONE; CHROMIUM DERIVATIVE; COBALT COMPLEX; COPPER COMPLEX; IRON COMPLEX; METAL COMPLEX; NICKEL COMPLEX; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACILLUS CEREUS; BACTERIAL GROWTH; BACTERIUM CULTURE; COMPLEX FORMATION; CULTURE MEDIUM; DRUG EFFICACY; DRUG SYNTHESIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; REACTION ANALYSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS UBERIS;

EID: 4344560284     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. AMBROGI, V.; ARTINI, D.; DE CARNERI, I.; CASTELLINO, S.; DRADI, E.; LOGEMANN, W.; MEINARDI, G.; DI SOMMA, M.; TOSOLINI, G. Studies on the antibacterial and antifungal properties of 1,4-naphthoquinones. Br. J. Pharmacol., v.40, p.871-880, 1970.
2. BOGDANOV, P.M.; ALBESA, I.; SPERANDEO, N.R.; LUNA, C.; BERTORELLO, M.M. Antibacterial effect of 2-hydroxy-N-(3,4-dimethyl-5-isoxazolyl)-1,4- naphthoquinone-4-imine on Staphylococcus aureus. Experientia, v.52, p.600-604, 1996.
3. BRINKWORTH, R.I.; FAIRLIE, D.P. Hydroxyquinones are competitive nonpeptide inhibitors of of HIV-1 proteinase. Biochim. Biophys. Acta, v. 1253, p.5-8, 1995.
4. CHOPRA, I.; HAWKEY, P.M.; HINTON, M. Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother., v.29, p.245-257, 1991.
5. CHRISTIANOPOULOU, M.N.B.; ECATERINIADOU, L.B.; SARRIS, K.J. Evaluation of the antimicrobial activity of a new series of hydroxy-quinone chelates of some transition metals. Eur. J. Med. Chem., v.21, p.385-390, 1986.
6. COULADOUROS, E.A.; PLYTA, Z.F.; PAPAGEORGIOU, V.P. A general procedure for the efficient synthesis of (alkylamino)naphthoquinones. J. Org. Chem., v.61, p.3031-3033, 1996.
7. DIDRY, N.; PINKAS, M.; DUBREIL, L. Activité antibacterienne de naphthoquinones d'origine végetale. Ann. Pharmac. Françaises, v.44, p.73-78, 1986.
8. EMORI, T.G.; GAYNES, R.P. An overview of nosocomial infections, including the role of the microbiology laboratoy. Clin. Microbiol. Rev., v.6, p.428-442, 1993.
9. FARIÑA, F.; MARTÍNEZ-UTRILLA, R.; PAREDES, M.C.; STEFANI, V. Synthesis of 5-amino-8-hydroxy-1,4-naphthoquinone and derivatives. Synthesis, v.8, p.781-784, 1985.
10. GERSHON, H.; SHANKS, L. Fungitoxicity of 1,4-naphthoquinones to Candida albicans and Trichophyton mentagrophytes. Can. J. Microbiol., v.21, p.1317-1321, 1975.
11. IQBAL, M.S.; AHMAD, A.R.; SABIR, M.; ASAD, S.M. Preparation, characterization and biological evaluation of copper(II) and zinc(II) complexes with cephalexin. J. Pharm. Pharmacol., v.51, p.371-375, 1999.
12. JOSHI, C.R. Metal chelates of juglones and their antimicrobial activity. Indian J. Pharmacol. Sci., v.48, p.101-104, 1986.
13. LECOMTE, S.; BARON, M.H.; CHENON, M.T.; COUPRY, C.; MOREAU, N.J. Effect of magnesium complexation by fluoroquinolones on their antibacterial activity. Antimicrob. Agents Chemother., v.38, p.2810-2816, 1994.
14. 3- thiosemicarbazone. J. Inorg. Biochem., v.78, p. 167-174, 2000.
15. LIPSITCH, M. The rise and fall of antimicrobial resistance. Trends Microbiol., v.9, p.438-444, 2001.
16. MACHADO, T.B.; PINTO, A.V.; PINTO, M.C.F.; LEAL, I.C.R.; SILVA, M.G.; AMARAL, A.C.F.; KUSTER, R.M.; SANTOS, K.R.N. In vitro activity of Brazilian medicinal plants, naturally occurring naphthoquinones and their analogues, against methicillin-resistant Staphylococcus aureus. Int. J. Antimicrob. Agents, v.21, p.279-284, 2003.
17. MARTINELLI, M.; STEFANI, V.; GERBASE, A.E.; FARIAS, M. Synthesis of 5-dodecanoylamine-8-hydroxy-1,4-naphtoquinone and study of some of its bivalent metal chelates. J. Coord. Chem., v.48, p.529-539, 1999.
18. MARTINELLI, M.; STEFANI, V.; GERBASE, A.E.; FARIAS, M.; AVILA, M.J. Comparative sites for coordination of naphthoquinones and its derivatives: studies on the synthesis of a series of 1,4-naphthoquinones derivatives and on their Ni(II) complexes. J. Coord. Chem., v.51, p.349-360, 2000.
19. MASUDA, K.; FUNAYAMA, S.; KOMIYAMA, K.; UMEZAWA, I.; ITO, K. Constituents of Tritonia crocosmaeflora, I. Tricizarin A, a novel antimicrobial naphthazarin derivative. J. Nat. Prod., v.50, p.418-421, 1987.
20. MERUELO, D.; JAVIE, G.; LAVIE, D. Therapeutic agents with dramatic retroviral activity and little toxicity at effective doses: aromatic polyciclic diones hypericin and pseudohypericin. Proc. Natl. Acad. Sci. USA, v.85, p.5230-5234, 1988.
21. th informational supplement. Approved standard M2-A7 and M7-A5. Wayne: NCCLS, 2001. p.10-42.
22. OLIVEIRA, C.G.T.; MIRANDA, F.F.; FERREIRA, V.F.; FREITAS, C.C.; RABELLI, R.F.; CARBALLIDO, J.M.; CORREA, L.C.D. Synthesis and antimicrobial evaluation of 3-hydrazino-naphthoquinones as analogs of lapachol. J. Braz. Chem. Soc., v. 12, p.339-345, 2001.
23. PAPAGEORGIOU, V.P.; ASSIMOPOULOU, A.N.; COULADOUROS, E.A.; HEPWORTH, D.; NICOLAOU, K.C. The chemistry and biology of alkannin, shikonin, and related naphthazarin natural products. Angewdte Chem. Int., v.38, p.270-300, 1999.
24. PIATNICKI, C.M.S.; AZAMBUJA, D.S.; STEFANI, V.; MARTINELLI, M.; GERBASE, A.E.; RECH, V.; RHODEN, A.V. Caracterização do ligante 5-acetilamino-8-hidroxi-1,4-naftoquinona e seu complexo de Ni(II). In: XII CONGRESO IBEROAMERICANO DE ELECTROQUIMICA, 12., Viña del Mar, 1996. Abstracts. Merida: Sociedad Iberoamericana de Electroquimica, 1996. v.1, p.568-569.
25. RIFFEL, A.; MEDINA, L.F.; STEFANI, V.; SANTOS, R.C.; BIZANI, D.; BRANDELLI, A. In vitro antimicrobial activity of a new series of 1,4 naphthoquinones. Braz. J. Med. Biol. Res., v.35, p.811-818, 2002.
26. SASAKI, K.; ABE, H.; YOSHIZAKI, F. In vitro antifungal activity of naphthoquinone derivatives. Biol. Pharm. Bull., v.25, p.669-670, 2002.
27. SMILACK, J.D.; WILSON, W.R.; COCKERILL, F.R. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clinic Proc., v.66, p.1270-1280, 1990.
28. THOMSON, R.H. Naturally Occurring Quinones. London: Academic Press, 1971. 732p.
29. WALLIS, S.C.; CHARLES, B.G.; GAHAN, L.R.; FILIPPICH, L.J.; BREDHAUER, M.G.; DUCKWORTH, P.A. Interaction of norfloxacin with divalent and trivalent pharmaceutical cations. In vitro complexation and in vivo pharmacokinetic studies in the dog. J. Pharm. Sci., v.85, p.803-809, 1996.
30. YOUNG, R.C.; OZOLS, R.F.; MYERS, C.E. The anthracycline antineoplasic drugs. New Engl. J. Med., v.305, p.139-153, 1981.